Skip to main content
Erschienen in: Odontology 3/2019

21.01.2019 | Original Article

Association between breast cancer chemotherapy, oral health and chronic dental infections: a pilot study

verfasst von: Ines Willershausen, Irene Schmidtmann, Adriano Azaripour, Jane Kledtke, Brita Willershausen, Annette Hasenburg

Erschienen in: Odontology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Breast cancer has developed to become the leading type of cancer in females. For this study, 80 women were examined after chemotherapy for breast cancer and compared to 80 healthy age-matched women. This cross-sectional study comprised a dental examination with number of teeth, caries frequency (DMFT) and the presence of periodontal diseases (PSI). With the help of X-rays (OPG), the number of root canal fillings and apical lesions (LEO/LPO) were recorded. Furthermore, the education level, body mass index (BMI), smoking habits and general health conditions were recorded. All women completed questionnaires on oral health-related quality of life (OHIP-G14) and general well-being (HADS-D). To assess the influence of cancer therapy on oral health parameters, appropriate generalized linear models were fitted with disease status as main explanatory variable, adjusting for age and education. For OHIP and HADS, we additionally adjusted for number of missing teeth. The examined 160 women showed a comparable mean age (60.4 years) and an average BMI of 24.6. Cancer patients showed a higher risk for missing teeth (p < 0.001) and more apical lesions (p < 0.0041), particularly those of endodontic origin without root canal fillings (p = 0.0046), than the control women. The general well-being of cancer patients was significantly reduced with a HADS score of 9.4 for women with breast cancer compared to 5.3 for the healthy control. This study suggests that women after breast cancer chemotherapy are inclined to have a poorer oral health status with more missing teeth and apical lesions. Therefore, tightly scheduled dental recall visits should be recommended.
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRef
2.
Zurück zum Zitat DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA: a Cancer. J Clin. 2014;64:52–62. DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA: a Cancer. J Clin. 2014;64:52–62.
3.
Zurück zum Zitat Cedolini C, Bertozzi S, Londero AP, et al. Type of breast cancer diagnosis, screening, and survival. Clin Breast Cancer. 2014;14:235–40.CrossRefPubMed Cedolini C, Bertozzi S, Londero AP, et al. Type of breast cancer diagnosis, screening, and survival. Clin Breast Cancer. 2014;14:235–40.CrossRefPubMed
4.
Zurück zum Zitat Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30.CrossRef Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30.CrossRef
5.
Zurück zum Zitat Sledge GW, Mamounas EP, Hortobagyi GN, Burstein HJ, Goodwin PJ, Wolff AC. Past, present, and future challenges in breast cancer treatment. J Clin Oncol. 2014;32:1979–86.CrossRefPubMedPubMedCentral Sledge GW, Mamounas EP, Hortobagyi GN, Burstein HJ, Goodwin PJ, Wolff AC. Past, present, and future challenges in breast cancer treatment. J Clin Oncol. 2014;32:1979–86.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Segura PP, Fombella JP, Lorenzo BP, Martin MR, Lopez PG. SEOM guide to primary and secondary prevention of cancer: 2014. Clin Transl Oncol. 2014;16:1072–8.CrossRefPubMedPubMedCentral Segura PP, Fombella JP, Lorenzo BP, Martin MR, Lopez PG. SEOM guide to primary and secondary prevention of cancer: 2014. Clin Transl Oncol. 2014;16:1072–8.CrossRefPubMedPubMedCentral
7.
8.
Zurück zum Zitat Anderson KN, Schwab RB, Martinez ME. Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat. 2014;144:1–10.CrossRefPubMedPubMedCentral Anderson KN, Schwab RB, Martinez ME. Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat. 2014;144:1–10.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Lohrisch C, Piccart M. Breast cancer: new aspects of adjuvant hormonal therapy. Ann Oncol. 2000;11(Suppl 3):13–25.CrossRefPubMed Lohrisch C, Piccart M. Breast cancer: new aspects of adjuvant hormonal therapy. Ann Oncol. 2000;11(Suppl 3):13–25.CrossRefPubMed
10.
Zurück zum Zitat Johnston SR. The role of chemotherapy and targeted agents in patients with metastatic breast cancer. Eur J Cancer. 2011;47(Suppl 3):38–47.CrossRef Johnston SR. The role of chemotherapy and targeted agents in patients with metastatic breast cancer. Eur J Cancer. 2011;47(Suppl 3):38–47.CrossRef
11.
Zurück zum Zitat Del Barco S, Ciruelos E, Tusquets I, Ruiz M, Barnadas A. SEOM clinical guidelines for the systemic treatment of early breast cancer 2013. Clin Transl Oncol. 2013;15:1011–7.CrossRefPubMed Del Barco S, Ciruelos E, Tusquets I, Ruiz M, Barnadas A. SEOM clinical guidelines for the systemic treatment of early breast cancer 2013. Clin Transl Oncol. 2013;15:1011–7.CrossRefPubMed
12.
Zurück zum Zitat Llombart Cussac A, de la Haba Rodriguez J, Ruiz Simon A, Alvarez Lopez I, Cortes Castan J. SEOM clinical guidelines for the management of metastatic breast cancer 2013. Clin Transl Oncol. 2013;15:1004–10.CrossRefPubMed Llombart Cussac A, de la Haba Rodriguez J, Ruiz Simon A, Alvarez Lopez I, Cortes Castan J. SEOM clinical guidelines for the management of metastatic breast cancer 2013. Clin Transl Oncol. 2013;15:1004–10.CrossRefPubMed
13.
Zurück zum Zitat Greene D, Nail LM, Fieler VK, Dudgeon D, Jones LS. A comparison of patient-reported side effects among three chemotherapy regimens for breast cancer. Cancer Practice. 1994;2:57–62.PubMed Greene D, Nail LM, Fieler VK, Dudgeon D, Jones LS. A comparison of patient-reported side effects among three chemotherapy regimens for breast cancer. Cancer Practice. 1994;2:57–62.PubMed
14.
Zurück zum Zitat Sitzia J, Huggins L. Side effects of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy for breast cancer. Cancer Practice. 1998;6:13–21.CrossRefPubMed Sitzia J, Huggins L. Side effects of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy for breast cancer. Cancer Practice. 1998;6:13–21.CrossRefPubMed
15.
Zurück zum Zitat Mayor S. Side-effects of cancer drugs are under-reported in trials. Lancet Oncol. 2015;16:e107.CrossRefPubMed Mayor S. Side-effects of cancer drugs are under-reported in trials. Lancet Oncol. 2015;16:e107.CrossRefPubMed
16.
Zurück zum Zitat Sanguineti G, Sormani MP, Marur S, et al. Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2012;83:235–42.CrossRefPubMed Sanguineti G, Sormani MP, Marur S, et al. Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2012;83:235–42.CrossRefPubMed
17.
Zurück zum Zitat Thorpe D, Stringer A, Butler R. Chemotherapy-induced mucositis: the role of mucin secretion and regulation, and the enteric nervous system. Neurotoxicology. 2013;38:101–5.CrossRefPubMed Thorpe D, Stringer A, Butler R. Chemotherapy-induced mucositis: the role of mucin secretion and regulation, and the enteric nervous system. Neurotoxicology. 2013;38:101–5.CrossRefPubMed
18.
Zurück zum Zitat Van Sebille YZ, Stansborough R, Wardill HR, Bateman E, Gibson RJ, Keefe DM. Management of mucositis during chemotherapy: from pathophysiology to pragmatic therapeutics. Curr Oncol Rep. 2015;17:50.CrossRefPubMed Van Sebille YZ, Stansborough R, Wardill HR, Bateman E, Gibson RJ, Keefe DM. Management of mucositis during chemotherapy: from pathophysiology to pragmatic therapeutics. Curr Oncol Rep. 2015;17:50.CrossRefPubMed
19.
Zurück zum Zitat Amodio J, Palioto DB, Carrara HH, Tiezzi DG, Andrade JM, Reis FJ. Oral health after breast cancer treatment in postmenopausal women. Clinics (Sao Paulo Brasil). 2014;69:706–8.CrossRef Amodio J, Palioto DB, Carrara HH, Tiezzi DG, Andrade JM, Reis FJ. Oral health after breast cancer treatment in postmenopausal women. Clinics (Sao Paulo Brasil). 2014;69:706–8.CrossRef
20.
Zurück zum Zitat Taichman LS, Griggs JJ, Inglehart MR. Periodontal health, perceived oral health, and dental care utilization of breast cancer survivors. J Public Health Dent. 2015;75:148–56.CrossRefPubMedPubMedCentral Taichman LS, Griggs JJ, Inglehart MR. Periodontal health, perceived oral health, and dental care utilization of breast cancer survivors. J Public Health Dent. 2015;75:148–56.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Mundt T, Schwahn C, Mack F, et al. Risk indicators for missing teeth in working-age Pomeranians—an evaluation of high-risk populations. J Public Health Dent. 2007;67:243–9.CrossRefPubMed Mundt T, Schwahn C, Mack F, et al. Risk indicators for missing teeth in working-age Pomeranians—an evaluation of high-risk populations. J Public Health Dent. 2007;67:243–9.CrossRefPubMed
22.
Zurück zum Zitat DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin. 2011;61:409–18.CrossRefPubMed DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin. 2011;61:409–18.CrossRefPubMed
23.
Zurück zum Zitat Alkan A, Cakmak O, Yilmaz S, Cebi T, Gurgan C. Relationship between psychological factors and oral health status and behaviours. Oral Health Prev Dent. 2015;13:331–9.PubMed Alkan A, Cakmak O, Yilmaz S, Cebi T, Gurgan C. Relationship between psychological factors and oral health status and behaviours. Oral Health Prev Dent. 2015;13:331–9.PubMed
24.
Zurück zum Zitat Kisely S, Sawyer E, Siskind D, Lalloo R. The oral health of people with anxiety and depressive disorders—a systematic review and meta-analysis. J Affect Disord. 2016;200:119–32.CrossRefPubMed Kisely S, Sawyer E, Siskind D, Lalloo R. The oral health of people with anxiety and depressive disorders—a systematic review and meta-analysis. J Affect Disord. 2016;200:119–32.CrossRefPubMed
25.
Zurück zum Zitat Harter M, Reuter K, Schretzmann B, Hasenburg A, Aschenbrenner A, Weis J. Comorbid psychiatric disorders in cancer patients in acute inpatient treatment and medical rehabilitation. Die Rehabilit. 2000;39:317–23.CrossRef Harter M, Reuter K, Schretzmann B, Hasenburg A, Aschenbrenner A, Weis J. Comorbid psychiatric disorders in cancer patients in acute inpatient treatment and medical rehabilitation. Die Rehabilit. 2000;39:317–23.CrossRef
26.
Zurück zum Zitat Farthmann J, Hanjalic-Beck A, Veit J, et al. The impact of chemotherapy for breast cancer on sexual function and health-related quality of life. Support Care Cancer. 2016;24:2603–9.CrossRefPubMed Farthmann J, Hanjalic-Beck A, Veit J, et al. The impact of chemotherapy for breast cancer on sexual function and health-related quality of life. Support Care Cancer. 2016;24:2603–9.CrossRefPubMed
27.
Zurück zum Zitat Pereira LJ, Braga Caputo J, Midori Castelo P, et al. Oral physiology and quality of life in cancer patients. Nutr Hosp. 2015;31:2161–6.PubMed Pereira LJ, Braga Caputo J, Midori Castelo P, et al. Oral physiology and quality of life in cancer patients. Nutr Hosp. 2015;31:2161–6.PubMed
28.
Zurück zum Zitat Taichman LS, Havens AM, Van Poznak CH. Potential implications of adjuvant endocrine therapy for the oral health of postmenopausal women with breast cancer. Breast Cancer Res Treat. 2013;137:23–32.CrossRefPubMed Taichman LS, Havens AM, Van Poznak CH. Potential implications of adjuvant endocrine therapy for the oral health of postmenopausal women with breast cancer. Breast Cancer Res Treat. 2013;137:23–32.CrossRefPubMed
29.
Zurück zum Zitat Napenas JJ, Brennan MT, Coleman S, et al. Molecular methodology to assess the impact of cancer chemotherapy on the oral bacterial flora: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endododontol. 2010;109:554–60.CrossRef Napenas JJ, Brennan MT, Coleman S, et al. Molecular methodology to assess the impact of cancer chemotherapy on the oral bacterial flora: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endododontol. 2010;109:554–60.CrossRef
Metadaten
Titel
Association between breast cancer chemotherapy, oral health and chronic dental infections: a pilot study
verfasst von
Ines Willershausen
Irene Schmidtmann
Adriano Azaripour
Jane Kledtke
Brita Willershausen
Annette Hasenburg
Publikationsdatum
21.01.2019
Verlag
Springer Japan
Erschienen in
Odontology / Ausgabe 3/2019
Print ISSN: 1618-1247
Elektronische ISSN: 1618-1255
DOI
https://doi.org/10.1007/s10266-019-00411-z

Weitere Artikel der Ausgabe 3/2019

Odontology 3/2019 Zur Ausgabe

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.